Compare Oruka Therapeutics Inc. Common Stock (ORKA) vs Invesco S&P 500 High Div Low Volatility ETF (SPHD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Oruka Therapeutics Inc. Common Stock vs Invesco S&P 500 High Div Low Volatility ETF — how do they compare? Oruka Therapeutics Inc. Common Stock trades at $77.89 (market cap $5.08B), while Invesco S&P 500 High Div Low Volatility ETF trades at $50.34 (market cap $3.20B). The key difference: Oruka Therapeutics Inc. Common Stock is the larger of the two by market cap, and Oruka Therapeutics Inc. Common Stock is more actively traded (685,276 versus 2,286,453). Which is the better fit depends on your goals — on Pluang, investors hold Oruka Therapeutics Inc. Common Stock for 0 Days and Invesco S&P 500 High Div Low Volatility ETF for 126 Days on average.
| ORKA | SPHD | |
|---|---|---|
Market Cap | $5.08B | $3.20B |
Volume | 685,276 | 2,286,453 |
Sector | Health | — |
52-Week High | $113.08 | $53.55 |
52-Week Low | $26.19 | $46.96 |
Typical Hold Time | 0 Days | 126 Days |
Enterprise Value | $4.21B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SPHD trades at $49.29, up 0.1% on the day, with a mixed technical picture showing a bullish overall signal but bearish moving averages. The ETF focuses on high dividend yield and low volatility, with recent dividends declared for July and September 2026. Media coverage highlights its monthly income appeal but questions long-term performance versus peers like SCHD.
Outlook hinges on its dividend strategy amid economic uncertainty; opportunities include steady income for retirees, but risks involve underperformance in growth markets and sensitivity to interest rate changes. Investors should weigh yield against total return potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →About Invesco S&P 500 High Div Low Volatility ETF
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. Strictly in accordance with its guidelines and mandated procedures, S&P Dow Jones Indices LLC (the “index Provider”) compiles, maintains and calculates the underlying index, which is designed to measure the performance of 50 least volatile high yielding constituents of the S&P 500 ® Index in the past year.
Read more on SPHD →
